Skip to content

Clinical trials

Phase 3 Homozygous Familial Hypercholesterolemia trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Homozygous Familial Hypercholesterolemia Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20192
20211
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Amgen1
Arrowhead Pharmaceuticals1
LIB Therapeutics LLC1
Regeneron Pharmaceuticals1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Homozygous Familial Hypercholesterolemia9
Hypercholesterolemia3
Hyperlipoproteinemia Type II3
Aortic Valve Stenosis1
Cardiovascular Diseases1
Dyslipidemias1
Heart Failure1
Hyperlipidemias1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.